Search

everythinglearnresearchcommunity

for

Search:↓

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Potential therapeutic targets for scarring hair loss are identified.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

Fucoidan reduces bone cell formation by affecting T-cell activity.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

Regulatory T cells help hair growth by using the Cxcr4-Cxcl12 pathway.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

γδ T cells are essential for wound healing after poxvirus infection.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

T cells and inflammation are crucial in atherosclerosis, with anti-inflammatory treatments showing promise.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

OX40-targeted therapies may help treat skin diseases by reducing inflammation and balancing immune responses.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Clonally expanded CD8+ T cells cause alopecia areata.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Regulatory T cells and mesenchymal stem cells work together to prevent immune system overreactions and tissue damage.

CTA is often mistaken for AA but doesn't respond to steroids and may require hair transplantation.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Cyclosporin doesn't stop hair loss.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Clinical signs don't match inflammation levels in lichen planopilaris and frontal fibrosing alopecia.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.